Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Other Working Capital Changes: 2016-2024

Historic Other Working Capital Changes for Solid Biosciences (SLDB) over the last 9 years, with Dec 2024 value amounting to $2.4 million.

  • Solid Biosciences' Other Working Capital Changes rose 78.06% to -$104,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $2.4 million, marking a year-over-year increase of 240.92%. This contributed to the annual value of $2.4 million for FY2024, which is 4350.23% up from last year.
  • Solid Biosciences' Other Working Capital Changes amounted to $2.4 million in FY2024, which was up 4,350.23% from $54,941 recorded in FY2023.
  • In the past 5 years, Solid Biosciences' Other Working Capital Changes ranged from a high of $20.7 million in FY2020 and a low of -$12.6 million during FY2021.
  • In the last 3 years, Solid Biosciences' Other Working Capital Changes had a median value of $54,941 in 2023 and averaged $845,491.
  • As far as peak fluctuations go, Solid Biosciences' Other Working Capital Changes plummeted by 161.00% in 2021, and later surged by 4,350.23% in 2024.
  • Solid Biosciences' Other Working Capital Changes (Yearly) stood at $20.7 million in 2020, then tumbled by 161.00% to -$12.6 million in 2021, then surged by 100.29% to $36,531 in 2022, then spiked by 50.40% to $54,941 in 2023, then skyrocketed by 4,350.23% to $2.4 million in 2024.